Clinical Trial Update: Serum and Exhaled Breath Condensate MALDI-MS of Lung Cancer. (SPORE)

View source ↗

Summary

This clinical trial update describes MALDI-MS analysis of serum and exhaled breath condensate in lung cancer under Vanderbilt's SPORE program. The study status …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Cancer

Snippet

Sponsor: Vanderbilt-Ingram Cancer Center | Conditions: Lung Cancer | Status: TERMINATED